News
FDA awards grant to study generic transplant drug tacrolimus
2014-04-22 The US Food and Drug Administration (FDA) has awarded a federal grant worth US$2.3 million to researchers at the University of Cincinnati, Ohio, USA, in… Read More »
Biosimilars naming debate intensifies
2014-04-17 In October 2013, a letter was sent to the US Food and Drug Administration (FDA) by a bipartisan group of US senators calling for biosimilars… Read More »
Etanercept biosimilar has comparable pharmacokinetics to Enbrel
2014-04-15 An etanercept biosimilar (CHS-0214) from fledgling biotech company Coherus Biosciences (Coherus) has shown comparable pharmacokinetics in a pivotal clinical study. Coherus announced on 28 October… Read More »
American-made prescription drugs 76% cheaper when purchased abroad
2014-04-10 American patients can make significant savings by buying drugs abroad, according to an analysis carried out by online pharmacy information specialist PharmacyChecker.com. Americans can find… Read More »
EMA launches public catalogue of drug shortages
2014-04-08 The European Medicines Agency (EMA) announced on 4 November 2013 the launch of its public catalogue on supply shortages of drugs. In the European Union,… Read More »
EGA commends EMA workshop on biosimilars guidelines
2014-04-03 The European Generic medicines Association (EGA) has congratulated the European Medicines Agency (EMA) on its organization of the EMA workshop on biosimilars and urges rapid… Read More »
FDA announces two actions to combat drug shortages
2014-04-01 The US Food and Drug Administration (FDA) announced on 31 October 2013 that it is taking two important actions to further enhance the agency’s ongoing… Read More »
Biosimilars: what patients need to know
2014-03-27 Biosimilars are medicines that are similar to a biological medicine that has already been authorized. Biosimilars are different to generics in that they are not… Read More »
Calls for biosimilars to have same INN at WHO meeting
2014-03-25 The World Health Organization (WHO) held its 57th Consultation on International Nonproprietary Names (INNs) for Pharmaceutical Substances on 22 October 2013 in Geneva, Switzerland. During… Read More »
Washington State legislation on biosimilars
2014-03-20 Biologicals manufacturers represented by the Biotechnology Industry Association (BIO) and the Washington Biotechnology & Biomedical Association have welcomed proposed Washington State legislation that will support… Read More »
